Medications for Opioid Use Disorder Differentially Modulate Intrinsically Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment (MOUD)
Opioid use disorder (OUD) is a treatable medical illness with three medications FDA approved for treatment. However, persons with OUD report significant sleep disturbance, even when treated with medications for opioid use disorder, leading to high rates of relapse. In this project, we will investigate a special set of photosensitive neurons in the retina as an underlying mechanism for circadian rhythm and sleep disturbance from opioid use and medications for OUD that could lead to novel intervention and improve treatment outcomes.
• Adults (18+)
• prescribed one of three medications for opioid use disorder (methadone, XR-NTX, buprenorphine) or healthy control
• stable on MOUD (no dose change) for the past month
• positive on urine drug screen (UDS) for buprenorphine or methadone if prescribed those medications